← FDA Drug Approvals (Drugs@FDA)

ARAZLO

NDA · New Drug Application · Sponsor: BAUSCH · Approved 2019-12-18

Drug application

FDA Application #

NDA211882

Application type

New Drug Application

Brand name

ARAZLO

Generic name

TAZAROTENE

Active ingredients

TAZAROTENE

Dosage form

LOTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

BAUSCH

Manufacturer

Bausch Health US, LLC

First approval

2019-12-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown